Markel Corp
F:MKV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Markel Corp
F:MKV
|
US |
|
A
|
Altria Group Inc
XMUN:PHM7
|
US |
|
P
|
Parker-Hannifin Corp
F:PAR
|
US |
|
Swedish Orphan Biovitrum AB (publ)
OTC:SWOBY
|
SE |
|
S
|
Swedish Orphan Biovitrum AB (publ)
F:B6E
|
SE |
|
S
|
Swedish Orphan Biovitrum AB (publ)
XMUN:B6E
|
SE |
Intrinsic Value
Is MKV undervalued or overvalued?
See the intrinsic value estimate for 
Markel Corp and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Markel Does
Markel Corp is an insurance holding company that makes money mainly by underwriting specialty insurance and collecting investment income from the premiums it holds before claims are paid. It writes hard-to-place business such as property, casualty, marine, and professional liability coverage, usually through wholesale brokers and specialized agents rather than direct consumer sales. Its main customers are businesses and individuals that need tailored coverage where standard insurers may not be a good fit.
- Headquarters
- United States of America US
- Employees
- 20 300
- IPO date
- Dec 12, 1986
Markel has no economic moat
Customers can choose among Markel and other insurers offering specialty coverage, so Markel’s products and expertise do not by themselves prevent rivals from competing for business. Buyers and brokers can seek comparable coverage elsewhere, limiting the protection provided by customer loyalty or Markel’s name.
Read the full moat analysis
The intrinsic value for Markel Corp (MKV) under the Base Case is hidden EUR.
Compared with the current market price of 1 733 EUR, the stock appears hidden.
